Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 10, 2004, Pages 1027-1032

  Van Outryve, Steven M ^a   Francque, Sven M ^a   Gentens, Paul A ^a   De Pauw, Filip F ^a   Van Den Bogaert, Erika ^a   Van Marck, Eric A ^a   Pelckmans, Paul A ^a   Michielsen, Peter P ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Bacillus Calmette Gu rin; Bladder carcinoma; Granulomatous hepatitis; Instillation; Mycobacterium bovis

Indexed keywords

AMINOTRANSFERASE; BCG VACCINE; EPIRUBICIN; ISONIAZID; MITOMYCIN C; PREDNISOLONE; RIFAMPICIN;

AGED; ANEMIA; ARTICLE; BACTERIUM CULTURE; BLADDER CARCINOMA; CASE REPORT; DRUG INDUCED DISEASE; DYSURIA; ENZYME ACTIVITY; GRANULOMATOUS HEPATITIS; HEMATURIA; HIGH RISK PATIENT; HUMAN; HYPERSENSITIVITY REACTION; HYPOALBUMINEMIA; IMMUNE RESPONSE; LEUKOPENIA; LIVER BIOPSY; LIVER TOXICITY; MALE; MYCOBACTERIUM BOVIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; ANTITUBERCULAR AGENTS; BCG VACCINE; BIOPSY; CARCINOMA, TRANSITIONAL CELL; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; HEPATITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISONIAZID; LIVER; MALE; PREDNISOLONE; RIFAMPIN; TRANSAMINASES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 6944225335     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200410000-00012     Document Type: Article

References (22)

1. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180-183.
2. De Jager R, Guinan P, Lamm D, Khanna O, Brosman S, De Kernion J, et al. Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette-Guerin. Overview analysis of six phase II clinical trials. Urology 1991; 38:507-513.
3. Lamm DL, van der Meijden APM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147:596-600.
4. Diaz C, Baldo C, Martin A, Fernandez MJ, Munoz M, Rodriguez L, et al. Tuberculosis parotidea secundaria a instilacion vesical con BCG: a proposito de un caso. Acta Otorrinolaringol Esp 2003; 54:129-133.
5. Peyrière H, Klouche K, Béraud JJ, Blayac JP, Hillaire-Buys D. Fatal systemic reaction after multiple doses of intravesical bacillus Calmette-Guérin for polyposis. Ann Pharmacother 2000; 34:1279-1282.
6. Armstrong RW. Complications after intravesical instillation of bacillus Calmette-Guérin: rhabdomyolysis and metastatic infection. J Urol 1991; 145:1264-1266.
7. Lamm DL. Complications of Bacillus Calmette-Guérin immunotherapy. Urol Clin North Am 1992; 19:565-572.
8. Steg A, Leleu C, Debré B, Boccon-Gibod L, Sicard D. Systemic bacillus Calmette-Guérin infection, 'BCG-itis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer. Eur Urol 1989; 16:161-164.
9. Kerckhaert W, Oosterlinck W. Intravesicale BCG-instillaties voor oppervlakkige blaastumoren. Een samenvatting voor de huisarts. Tijdschr Geneesk 2003; 59:915-919.
10. Witjes JA, van der Meijden AP, Debruyne FMJ. Use of intravesical Bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int 1990; 45:129-136.
11. Patard JJ, Guille F, Lobel B, Abbou CC, Chopin D. Etat actuel des connaissances sur les mecanismes d'action du B.C.G. Prog Urol 1998; 8:415-421.
12. Chang SG, Lee SJ, Huh JS, Lee JH. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy. Oncol Rep 2001; 8:257-261.
13. Jansson OT, Morcos E, Brundin L, Lundberg JO, Adolfsson J, Soderhall M, et al. The role of nitric oxide in bacillus Calmette-Guerin mediated anti-tumour effects in human bladder cancer. Br J Cancer 1998; 78: 588-592.
14. Kamphuis JT, Buiting AGM, Miseré JFMM, van Berge Henegouwen DP, van Soolingen D, Rensma PL. BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations. Neth J Med 2001; 58:71-75.
15. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-644.
16. Proctor DD, Chopra S, Rubenstein SC, Jokela JA, Uhl L. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Am J Gastroenterol 1993; 88:1112-1115.
17. Leebeek FWG, Ouwendijk RJT, Kolk AHJ, Dees A, Meek JCE, Nienhuis JE, et al. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation. Gut 1996; 38:616-618.
18. Graziano DA, Jacobs D, Lozano RG, Buck RL. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration. J Urol 1991; 146:1118-1119.
19. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Guérin for bladder cancer. N Engl J Med 1998; 339:831-837.
20. Molina JM, Rabian C, D'Agay MF, Modai J. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids. J Urol 1992; 147:695-697.
21. Whittaker JA, Bentley DP, Melville-Jones GR, Slater AJ. Granuloma formation in patients receiving BCG immunotherapy. J Clin Pathol 1976; 29:693-697.
22. Mukamel E, Konichezky M, Engelstein D, Cytron S, Abramovici A, Servadio C. Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guérin instillations. J Urol 1990; 144:1399-1400.